Post-earnings recap
Reported
Wed, Feb 26, 2025
EPS actual
$-0.28
EPS est.
$-0.21
EPS surprise
-33.97%
1-day move
-1.70%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Teladoc Health's earnings report indicates challenges with profitability, as evidenced by the EPS miss. The stock reacted negatively, declining by 1.7%. However, the company showed growth in member additions and visit volumes, which could be positive for future revenue despite the current losses.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.28 | N/A | -33.97% |
| Consolidated Revenue | $640 million | N/A | N/A |
| Integrated Care Revenue | $391 million | N/A | +2% |
| BetterHelp Revenue | $250 million | N/A | -9.5% |
Management expressed optimism about member growth and visit volume increases. They highlighted the performance of their international business as a key growth area.
We added over 4 million members in the U.S. and grew underlying visit volumes by 6%.
Our international integrated care business delivered mid-teens revenue growth in 2024.
We expect consolidated revenue for 2025 to range between $2.47 billion and $2.58 billion.